Spero Therapeutics
Price & Volume
Stats
See moreOpen | $1.91 |
Previous Close | $1.88 |
Day Range | $1.91-$1.97 |
52W Range | $0.50-$3.22 |
Market Cap | $106.9M |
Shares Short | 458,620 |
Financials
See moreRevenue (12 Mos) | $48.5M |
Revenue Growth (YoY) | 39.1% |
Gross Profit (12 Mos) | -$31.4M |
Diluted EPS | -$0.99 |
News
See moreYahoo Finance • 2 months ago
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
Yahoo Finance • 2 months ago
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
Yahoo Finance • 4 months ago
Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone
Yahoo Finance • 5 months ago
Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
About
CEO | Ms. Esther P. Rajavelu |
CFO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
